PER-080-03已完成未知
RANDOMIZED CLINICAL AND BIOLOGICAL STUDY: CHEMOTHERAPY VS CHIMIO-RADIOTERAPIA FOR GASTRIC LYMPHOMA NON-HODGKIN OF HIGH GRADE.
INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP,0 个研究点目标入组 0 人开始时间: 2004年1月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Histological diagnosis of non-Hodgkin lymphoma of high grade primary gastric clinical stage I, ll1, II2, IIE, without indication of emergency surgery.
- •2 No evidence of other neoplasms.
- •3 Evidence of measurable or evaluable injuries.
- •4 No previous treatment.
- •5 Age <70 years.
- •6 Status performance of 0-2.
- •7 Adequate spinal reserve- (WBCs> 4,000 mm3, neutrophils> 2,000 mm3, platelets> 120,000 min3.
- •8 Suitable renal and hepatic function
- •9 Life expectancy of more than three months.
- •10 Geographic accessibility or treatment.
- •11 Written consent.
排除标准
- •1 Severe cardiomyopathy.
- •2 Present or past history of second neoplasia (except carcinoma in-situ of cervix and basal cell carcinoma of skin).
- •3 Infections or metabolic disorders not controlled.
- •4 More than one month between the staging and the start of treatment.
- •5 Previous chemotherapy.
研究者
相似试验
进行中（未招募）
不适用
Strain sUrveillance during Chemotherapy for improving Cardiovascular OUtcomesACTRN12614000341628Menzies Research Institute Tasmania331
进行中（未招募）
1 期
Randomized clinical trial of concomitant chemoendocrine therapy versus chemotherapy followed by endocrine therapy as first line treatment of luminal B metastatic breast cancer.EUCTR2016-004107-31-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS300
进行中（未招募）
1 期
Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical CancerHigh-risk locally advanced cervical cancerMedDRA version: 21.1Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864EUCTR2019-003152-37-SEMerck Sharp & Dohme LLC980
进行中（未招募）
1 期
Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical CancerHigh-risk locally advanced cervical cancerMedDRA version: 21.1Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864EUCTR2019-003152-37-ITMERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC.980
进行中（未招募）
1 期
Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical CancerHigh-risk locally advanced cervical cancerMedDRA version: 21.1Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000004864EUCTR2019-003152-37-GRMerck Sharp & Dohme Corp., a subsidiary of Merck &Co.,Inc980